Positive XARELTO(R) Sleep Apnea Data
Craig Coleman, PharmD, FASHP, FACC, Professor at the University of Connecticut discusses new data supporting XARELTO ® (rivaroxaban) efficacy and safet...
179 articles
Craig Coleman, PharmD, FASHP, FACC, Professor at the University of Connecticut discusses new data supporting XARELTO ® (rivaroxaban) efficacy and safet...
Introduction Addiction is an intricate and formidable problem that extends its impact far beyond the individual facing it, profoundly affecting their fa...
Introduction The term "addictive personality" is used to describe individuals with a predisposition to develop addictions.
Katherine Tomasino, PhD, co-director of the Behavioral Medicine for Digestive Health Program at Northwestern Memorial Hospital in Chicago discusses the ...
Matt Zemon, MSc, author of the book "Psychedelics for Everyone: A Beginner’s Guide to These Powerful Medicines for Anxiety, Depression, Addiction, PTS...
Sebastian Seiguer, CEO of Scene Health, formerly emocha Health, and Dr. Learn more on Health Professional Radio.
Jamie Pagliaro, EVP and Chief Learning Officer of RethinkFirst, a software and solutions provider in behavioral health that offers evidence-based treatm...
Demian Bellumio, Chief Operating Officer and Co-Founder at Nue Life Health, a next-gen mental wellness company that leverages the power of psychedelic d...
Charlene Gamaldo, Medical Director of the Johns Hopkins Center for Sleep at Howard County General Hospital and Professor of Neurology, Johns Hopkins Uni...
Lisa Marie Clinton, founder of avail ® and Managing Director of avail Support at CentralReach, the leading provider of Autism and IDD care software, di...